Advertisement Astellas Pharma files lawsuit against Nycomed - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Astellas Pharma files lawsuit against Nycomed

Astellas Pharma and its US affiliate Astellas US have jointly filed a patent infringement lawsuit against Nycomed US (Nycomed) in the US, in response to its submission of an abbreviated new drug application for a generic version of Astellas 0.1% Tacrolimus ointment, which is sold under the trademark, Protopic.